Patents
Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
06/2000
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2355896A1 Antibodies to truncated vegf-d and uses thereof
06/27/2000US6080397 Infusion or surgical rinse colloidal solutions of polyvinylpyrrolidone (pvp) of given molecular weight; free of impurities and high molecular weight pvp, and having low: amine content, peroxide, and solvent; nonallergenic
06/22/2000WO2000035420A2 Stable surgical irrigating solutions
06/15/2000WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
06/15/2000DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use
06/08/2000WO2000032577A2 Substituted benzo[de]isoquinoline-1,3-diones
06/08/2000CA2352045A1 Substituted benzo[de]isoquinoline-1,3-diones
06/07/2000EP1005337A1 Pharmacologic drug combination in vagal-induced asystole
06/02/2000WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
05/2000
05/31/2000EP1003493A1 Use of selective rxr agonists to prevent surgical adhesions
05/24/2000EP1002083A1 Aprotinin variants with improved properties and bikunins of aprotinin variants
05/24/2000EP1001790A1 Compositions for lubricating and separating tissues and biological membranes
05/18/2000WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use
05/18/2000CA2350182A1 Connective tissue growth factor (ctgf) and methods of use
05/16/2000US6063061 Fragmented polymeric compositions and methods for their use
05/11/2000WO2000025745A2 Irrigation solution and method for inhibition of pain and inflammation
05/04/2000WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/04/2000WO2000012072A3 The use of fumaric acid derivatives in transplant medicine
05/02/2000US6056970 Compositions comprising hemostatic compounds and bioabsorbable polymers
04/2000
04/27/2000WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L
04/13/2000WO2000020642A1 Prevention of adhesions
04/13/2000CA2354863A1 Prevention of adhesions
04/12/2000EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents
03/2000
03/23/2000DE19910654A1 Calcium and magnesium-free infusion solution for macular surgery, having improved retina loosening effect
03/14/2000US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion
03/09/2000WO2000012683A2 Stem cells bearing an fgf receptor on the cell surface
03/09/2000WO2000012072A2 The use of fumaric acid derivatives in transplant medicine
03/09/2000DE19839566A1 Verwendung von Fumarsäurederivaten in der Transplantationsmedizin Use of fumaric acid derivatives in transplantation
03/09/2000CA2341754A1 Stem cells bearing an fgf receptor on the cell surface
03/08/2000CN1246791A Compositions and methods for treating or preventing inflammatory diseases
03/02/2000WO2000011147A1 Inbred mhc-homozygous miniature swine and uses thereof
02/2000
02/24/2000WO2000009087A1 Methods for forming regional tissue adherent barriers and drug delivery systems
02/17/2000WO2000007659A1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
02/17/2000WO2000007515A1 Improved method for targeted topical treatment of disease
02/02/2000EP0976776A1 Hypertonic aqueous dispersions of unfractioned collagen, a method and a device for the preparation of said dispersions
02/01/2000US6020326 Method for inhibition of bone growth by anionic polymers
01/2000
01/20/2000WO2000002912A2 Disintegrin homologs
01/20/2000CA2332311A1 Disintegrin homologs
01/19/2000EP0859751B1 Semi-fluorinated alkanes and their use
01/19/2000EP0847240A4 Novel embolizing compositions
01/18/2000US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
01/13/2000WO2000001428A1 Diphasic injection composition, in particular useful in reparative and plastic surgery
01/12/2000EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
12/1999
12/29/1999CN1239657A Antisticking particle and powder containing sodium hyaluronate and their preparation process
12/28/1999US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/22/1999EP0965334A1 Liquid respiratory product for intubation
12/22/1999EP0965329A1 Skin treatment agents and use thereof for preparing dermatological compositions
12/07/1999US5998481 Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
12/07/1999US5998364 Component B as cicatrizant
11/1999
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/18/1999WO1999058168A1 Dextrin-containing composition for preventing surgical adhesions
11/11/1999WO1999056798A1 Compositions comprising hemostatic compounds and bioabsorbable polymers
11/11/1999CA2329809A1 Compositions comprising hemostatic compounds and bioabsorbable polymers
11/04/1999WO1999055382A1 Adenoviral vector encoding anti-apoptotic bcl-2 gene and uses thereof
11/04/1999WO1999055304A1 Methods and compositions for stabilizing acetylcholine compositions
10/1999
10/21/1999WO1999042137A3 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
10/14/1999WO1999051244A1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
09/1999
09/15/1999EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases
09/15/1999CN1228779A Spirocyclic metalloprotease inhibitors
09/10/1999WO1999044584A1 Emulsion preconcentrates containing cyclosporin or a macrolide
09/02/1999WO1999043663A1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
09/02/1999CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia
08/1999
08/26/1999WO1999042137A2 Stress promoter control of therapeutic genes in gene therapy: compositions and methods
08/18/1999CN1226132A Solution and process for resuscitation and reparation of ischemically damaged tissue
08/17/1999US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/10/1999US5935942 Co-administering a fluorescent dye encapsulated within a heat-sensitive liposome and tissue reactive agent activated by irradiation, selectively heating, monitoring, activating by irradiating
07/1999
07/28/1999EP0930878A1 Use of sodium 2-mercaptoethanesulfonate in surgery
07/07/1999EP0927183A1 Spirocyclic metalloprotease inhibitors
07/07/1999EP0927053A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation
06/1999
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
05/1999
05/14/1999WO1999022747A1 Bonding of cartilaginous matrices using isolated chondrocytes
05/14/1999CA2307743A1 Bonding of cartilaginous matrices using isolated chondrocytes
05/06/1999EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency
04/1999
04/29/1999WO1999020297A1 Prevention and treatment of adhesion formation
04/29/1999WO1999020293A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/29/1999CA2306983A1 Methods for treating hypercoagulable states or acquired protein c deficiency
04/15/1999WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents
04/07/1999CN1213309A Control of healing process
03/1999
03/17/1999EP0901385A1 A process of composition for medical use
03/17/1999EP0717634A4 Injectable compositions for soft tissue augmentation
03/04/1999WO1999009973A1 Pharmacologic drug combination in vagal-induced asystole
02/1999
02/17/1999CN1208338A Composition and method for acceleration of wound and burn healing
02/17/1999CN1207920A Composite sea-buckthorn oil capsule
02/11/1999WO1999006036A1 Use of selective rxr agonists to prevent surgical adhesions
02/11/1999CA2295807A1 Use of selective rxr agonists to prevent surgical adhesions
02/10/1999EP0895478A1 Component b as cicatrizant
02/09/1999US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders
01/1999
01/28/1999WO1999003481A1 Compositions for lubricating and separating tissues and biological membranes
01/28/1999CA2296280A1 Compositions for lubricating and separating tissues and biological membranes
01/21/1999WO1999002168A1 Novel polymeric compositions
01/19/1999US5860950 Arthroscopic irrigation solution and method for inhibition of pain and inflammation
01/12/1999US5858017 Urologic irrigation solution and method for inhibition of pain, inflammation and spasm
01/06/1999CN1203790A Medicine for curing and operating purpose and its preparing method
12/1998
12/23/1998WO1998057651A1 Compositions and methods for preventing restenosis following revascularization procedures
12/17/1998WO1998056916A1 Aprotinin variants with improved properties and bikunins of aprotinin variants
12/17/1998DE19725014A1 Aprotininvarianten mit verbesserten Eigenschaften und Bikunine von Aprotininvarianten Aprotinin variants with improved properties and Bikunine of aprotinin
12/01/1998US5843024 Solution and process for resuscitation and preparation of ischemically damaged tissue
11/1998
11/18/1998CN1199343A Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivs.
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38